David M. Weber - Nov 3, 2021 Form 4 Insider Report for ABIOMED INC (ABMD)

Role: Chief Operating Officer
Signature: /s/ Marc. A Began (by power of attorney)
Stock symbol: ABMD
Transactions as of: Nov 3, 2021
Transactions value $: -$541,778
Form type: 4
Date filed: 11/5/2021, 04:29 PM
Previous filing: Jun 2, 2021
Next filing: Feb 9, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ABMD	Common Stock, $.01 par value	Award	$0	+6.98K	+5.54%	$0.00	133K	Nov 3, 2021	Direct	F5
transaction	ABMD	Common Stock, $.01 par value	Tax liability	-$542K	-1.55K	-1.17%	$349.76	131K	Nov 3, 2021	Direct	F4
holding	ABMD	Common Stock, $.01 par value						15.5K	Nov 3, 2021	By Trust

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	ABMD	Stock Option (Right to Buy)						10.8K	Nov 3, 2021	Common Stock	0	$21.55	Direct	F1, F2
holding	ABMD	Stock Option (right to buy)						10K	Nov 3, 2021	Common Stock	0	$66.25	Direct	F1, F2
holding	ABMD	Stock Option (right to buy)						7K	Nov 3, 2021	Common Stock	0	$99.62	Direct	F2, F3
holding	ABMD	Stock Option (right to buy)						8K	Nov 3, 2021	Common Stock	0	$134.51	Direct	F2, F3
holding	ABMD	Stock Option (right to buy)						6.5K	Nov 3, 2021	Common Stock	0	$381.97	Direct	F2, F3
holding	ABMD	Stock Option (Right to Buy)						6K	Nov 3, 2021	Common Stock	0	$266.39	Direct	F2, F3
holding	ABMD	Stock Option (Right to Buy)						5K	Nov 3, 2021	Common Stock	0	$223.90	Direct	F2, F3
holding	ABMD	Stock Option (Right to Buy)						4.97K	Nov 3, 2021	Common Stock	0	$283.88	Direct	F2, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2008 Stock Incentive Plan.
F2	These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
F3	Grant to reporting person of option to buy the number of shares of Common Stock set forth in Table II, Column 7, under the ABIOMED, Inc. 2015 Omnibus Incentive Plan.
F4	Transaction represents shares of common stock withheld solely for the payment of withholding tax liability associated with the vesting of awards of restricted stock units in accordance with the time periods set forth in such awards.
F5	Represents shares of common stock underlying performance-based awards of restricted stock units granted to this reporting person on November 5, 2020. One half of these restricted stock units vested on November 3, 2021 (into an equal number of shares of common stock) based on the issuer's achievement of a certain performance milestone with the remaining vesting on the second anniversary of the date of grant as long as the reporting person continues to be employed by the issuer on the vesting dates.